TipRanks
Advertisement
Advertisement

JP:4552 Stock Latest News

Italfarmaco Secures Exclusive Rights to JCR’s Hunter Syndrome Therapy JR-141 in Key Global Markets
Company AnnouncementsItalfarmaco Secures Exclusive Rights to JCR’s Hunter Syndrome Therapy JR-141 in Key Global Markets
9d ago
4552
JCR Pharmaceuticals Deepens Fucosidosis Research With New Long-Term Patient Study
PremiumCompany Announcements
JCR Pharmaceuticals Deepens Fucosidosis Research With New Long-Term Patient Study
2M ago
4552
JCR Pharmaceuticals Posts Wider Quarterly Loss but Keeps Earnings and Dividend Outlook Intact
PremiumCompany Announcements
JCR Pharmaceuticals Posts Wider Quarterly Loss but Keeps Earnings and Dividend Outlook Intact
2M ago
4552
JCR Pharmaceuticals Releases FY2026 Q1 Briefing Materials With Key Investor Disclaimers
PremiumCompany Announcements
JCR Pharmaceuticals Releases FY2026 Q1 Briefing Materials With Key Investor Disclaimers
2M ago
4552
JCR Pharmaceuticals Completes Restricted Stock Compensation Transaction
PremiumCompany Announcements
JCR Pharmaceuticals Completes Restricted Stock Compensation Transaction
3M ago
4552
JCR Pharmaceuticals Sets 2026–2027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan
PremiumCompany AnnouncementsJCR Pharmaceuticals Sets 2026–2027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan
3M ago
4552
JCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
Premium
Company Announcements
JCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
4M ago
4552
JCR Pharmaceuticals Corrects FY2024 Results as Weak Performance Prompts Closer Scrutiny
Premium
Company Announcements
JCR Pharmaceuticals Corrects FY2024 Results as Weak Performance Prompts Closer Scrutiny
4M ago
4552
JCR Pharmaceuticals to Grant Restricted Treasury Shares as Long-Term Incentive
PremiumCompany Announcements
JCR Pharmaceuticals to Grant Restricted Treasury Shares as Long-Term Incentive
4M ago
4552
JCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
PremiumCompany Announcements
JCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
4M ago
4552
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
PremiumCompany Announcements
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
4M ago
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
PremiumCompany Announcements
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
5M ago
4552
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
PremiumCompany AnnouncementsJCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
5M ago
4552
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
Premium
Company Announcements
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
5M ago
4552
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
Premium
Company Announcements
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
5M ago
4552
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
PremiumCompany Announcements
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
5M ago
4552
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
PremiumCompany Announcements
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
5M ago
4552
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
PremiumCompany Announcements
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
5M ago
4552
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
PremiumCompany Announcements
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
5M ago
4552
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
PremiumCompany AnnouncementsJCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
8M ago
4552
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
Premium
Company Announcements
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
9M ago
4552
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
Premium
Company Announcements
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
9M ago
4552

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >